Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response

Venezuelan equine encephalitis virus (VEEV), a New World alphavirus of the Togaviridae family of viruses causes periodic outbreaks of disease in humans and equines. Disease following VEEV infection manifests as a febrile illness with flu-like symptoms, which can progress to encephalitis and cause pe...

Full description

Bibliographic Details
Main Authors: Ahmed, Aslaa, Bakovic, Allison, Risner, Kenneth, Kortchak, Stephanie, Der Torossian Torres, Marcelo, de la Fuente-Nunez, Cesar, Lu, Timothy, Bhalla, Nishank, Narayanan, Aarthi
Format: Article
Language:English
Published: Springer Science and Business Media LLC 2021
Online Access:https://hdl.handle.net/1721.1/133660
_version_ 1826205884121874432
author Ahmed, Aslaa
Bakovic, Allison
Risner, Kenneth
Kortchak, Stephanie
Der Torossian Torres, Marcelo
de la Fuente-Nunez, Cesar
Lu, Timothy
Bhalla, Nishank
Narayanan, Aarthi
author_facet Ahmed, Aslaa
Bakovic, Allison
Risner, Kenneth
Kortchak, Stephanie
Der Torossian Torres, Marcelo
de la Fuente-Nunez, Cesar
Lu, Timothy
Bhalla, Nishank
Narayanan, Aarthi
author_sort Ahmed, Aslaa
collection MIT
description Venezuelan equine encephalitis virus (VEEV), a New World alphavirus of the Togaviridae family of viruses causes periodic outbreaks of disease in humans and equines. Disease following VEEV infection manifests as a febrile illness with flu-like symptoms, which can progress to encephalitis and cause permanent neurological sequelae in a small number of cases. VEEV is classified as a category B select agent due to ease of aerosolization and high retention of infectivity in the aerosol form. Currently, there are no FDA-approved vaccines or therapeutics available to combat VEEV infection. VEEV infection in vivo is characterized by extensive systemic inflammation that can exacerbate infection by potentially increasing the susceptibility of off-site cells to infection and dissemination of the virus. Hence, a therapeutic targeting both the infection and associated inflammation represents an unmet need. We have previously demonstrated that host defense peptides (HDPs), short peptides that are key components of the innate immune response, exhibit antiviral activity against a multitude of viruses including VEEV. In this study, we designed synthetic peptides derived from indolicidin, a naturally occurring HDP, and tested their efficacy against VEEV. Two candidate synthetic peptides inhibited VEEV replication by approximately 1000-fold and decreased the expression of inflammatory mediators such as IL1α, IL1β, IFNγ, and TNFα at both the gene and protein expression levels. Furthermore, an increase in expression levels of genes involved in chemotaxis of leukocytes and anti-inflammatory genes such as IL1RN was also observed. Overall, we conclude that our synthetic peptides inhibit VEEV replication and the inflammatory burden associated with VEEV infection.
first_indexed 2024-09-23T13:20:34Z
format Article
id mit-1721.1/133660
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T13:20:34Z
publishDate 2021
publisher Springer Science and Business Media LLC
record_format dspace
spelling mit-1721.1/1336602021-10-28T03:53:32Z Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response Ahmed, Aslaa Bakovic, Allison Risner, Kenneth Kortchak, Stephanie Der Torossian Torres, Marcelo de la Fuente-Nunez, Cesar Lu, Timothy Bhalla, Nishank Narayanan, Aarthi Venezuelan equine encephalitis virus (VEEV), a New World alphavirus of the Togaviridae family of viruses causes periodic outbreaks of disease in humans and equines. Disease following VEEV infection manifests as a febrile illness with flu-like symptoms, which can progress to encephalitis and cause permanent neurological sequelae in a small number of cases. VEEV is classified as a category B select agent due to ease of aerosolization and high retention of infectivity in the aerosol form. Currently, there are no FDA-approved vaccines or therapeutics available to combat VEEV infection. VEEV infection in vivo is characterized by extensive systemic inflammation that can exacerbate infection by potentially increasing the susceptibility of off-site cells to infection and dissemination of the virus. Hence, a therapeutic targeting both the infection and associated inflammation represents an unmet need. We have previously demonstrated that host defense peptides (HDPs), short peptides that are key components of the innate immune response, exhibit antiviral activity against a multitude of viruses including VEEV. In this study, we designed synthetic peptides derived from indolicidin, a naturally occurring HDP, and tested their efficacy against VEEV. Two candidate synthetic peptides inhibited VEEV replication by approximately 1000-fold and decreased the expression of inflammatory mediators such as IL1α, IL1β, IFNγ, and TNFα at both the gene and protein expression levels. Furthermore, an increase in expression levels of genes involved in chemotaxis of leukocytes and anti-inflammatory genes such as IL1RN was also observed. Overall, we conclude that our synthetic peptides inhibit VEEV replication and the inflammatory burden associated with VEEV infection. 2021-10-27T19:54:02Z 2021-10-27T19:54:02Z 2020 2021-01-28T19:45:39Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/133660 en 10.1038/s41598-020-77990-3 Scientific Reports Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Springer Science and Business Media LLC Scientific Reports
spellingShingle Ahmed, Aslaa
Bakovic, Allison
Risner, Kenneth
Kortchak, Stephanie
Der Torossian Torres, Marcelo
de la Fuente-Nunez, Cesar
Lu, Timothy
Bhalla, Nishank
Narayanan, Aarthi
Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
title Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
title_full Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
title_fullStr Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
title_full_unstemmed Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
title_short Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
title_sort synthetic host defense peptides inhibit venezuelan equine encephalitis virus replication and the associated inflammatory response
url https://hdl.handle.net/1721.1/133660
work_keys_str_mv AT ahmedaslaa synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT bakovicallison synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT risnerkenneth synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT kortchakstephanie synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT dertorossiantorresmarcelo synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT delafuentenunezcesar synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT lutimothy synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT bhallanishank synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse
AT narayananaarthi synthetichostdefensepeptidesinhibitvenezuelanequineencephalitisvirusreplicationandtheassociatedinflammatoryresponse